| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
83
|
| CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
79
|
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
50
|
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
42
|
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
40
|
| RTEL1-TNFRSF6B |
|
RTEL1-TNFRSF6B readthrough (NMD candidate)
|
|
|
0.682 |
0.385 |
32
|
| GBAP1 |
|
glucosylceramidase beta pseudogene 1
|
|
|
0.623 |
0.538 |
29
|
| MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
25
|
| BDNF-AS |
|
BDNF antisense RNA
|
|
|
0.638 |
0.538 |
25
|
| LINC00824 |
|
long intergenic non-protein coding RNA 824
|
|
|
0.695 |
0.346 |
23
|
| TEX41 |
|
testis expressed 41
|
|
|
0.743 |
0.269 |
23
|
| LIPC-AS1 |
|
LIPC antisense RNA 1
|
|
|
0.839 |
0.154 |
22
|
| AQP4-AS1 |
|
AQP4 antisense RNA 1
|
|
|
0.751 |
0.577 |
22
|
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
21
|
| LINC00461 |
|
long intergenic non-protein coding RNA 461
|
|
|
0.736 |
0.423 |
21
|
| BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |
20
|
| ADAMTS9-AS2 |
|
ADAMTS9 antisense RNA 2
|
|
|
0.656 |
0.462 |
19
|
| IGF2-AS |
Q6U949
|
IGF2 antisense RNA
|
|
|
0.612 |
0.615 |
19
|
| SPRY4-AS1 |
|
SPRY4 antisense RNA 1
|
|
|
0.890 |
0.192 |
18
|
| PKN2-AS1 |
|
PKN2 antisense RNA 1
|
|
|
0.769 |
0.385 |
18
|
| APOA1-AS |
|
APOA1 antisense RNA
|
|
|
0.760 |
0.269 |
18
|
| LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
17
|
| CCND2-AS1 |
|
CCND2 antisense RNA 1
|
|
|
0.760 |
0.154 |
16
|
| LINC02245 |
|
long intergenic non-protein coding RNA 2245
|
|
|
0.821 |
0.231 |
16
|